Sheena Jonathan 4
4 · Natera, Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
Natera (NTRA) Co‑Founder Sheena Jonathan Sells Shares
What Happened
- Sheena Jonathan, a director and co‑founder of Natera, sold a total of 1,500 NTRA shares in several open‑market transactions on January 23, 2026. The filings report seven disposals: 160 @ $242.31 ($38,770), 185 @ $243.49 ($45,046), 355 @ $244.78 ($86,897), 50 @ $245.62 ($12,281), 200 @ $242.23 ($48,446), 160 @ $243.59 ($38,974), and 390 @ $244.87 ($95,500), for aggregate proceeds of roughly $365,914. These sales were effected under a trading plan (Rule 10b5‑1) adopted June 7, 2024.
Key Details
- Transaction date: January 23, 2026 (filed January 27, 2026 — within the Form 4 two business‑day filing window).
- Reported trades: seven open‑market sales totaling 1,500 shares; weighted‑average reported prices shown above.
- Proceeds: approximately $365,914 total.
- Shares owned after transaction: not specified in the filing.
- Notable footnotes: the filing notes sales were executed under a Rule 10b5‑1 plan and that several line items reflect weighted average prices with specified price ranges for the multiple executions; the filing also notes some securities are held for the benefit of trust beneficiaries and the reporting person disclaims beneficial ownership over those trust holdings. The filing states the holder will provide detailed per‑price breakdowns on written request.
Context
- These were outright sales (code S). Sales under pre‑arranged 10b5‑1 plans are common and often represent routine liquidity rather than an insider signal about company prospects. No purchases, option exercises, or gifts were reported in this filing.
Insider Transaction Report
Form 4
Natera, Inc.NTRA
Sheena Jonathan
DirectorOther
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-01-23$242.31/sh−160$38,770→ 22,372 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-01-23$243.49/sh−185$45,046→ 22,187 total(indirect: By Trust) - Sale
Common Stock
[F1][F5][F3]2026-01-23$244.78/sh−355$86,897→ 21,832 total(indirect: By Trust) - Sale
Common Stock
[F1][F3]2026-01-23$245.62/sh−50$12,281→ 21,782 total(indirect: By Trust) - Sale
Common Stock
[F1][F6][F3]2026-01-23$242.23/sh−200$48,446→ 22,332 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F3]2026-01-23$243.59/sh−160$38,974→ 22,172 total(indirect: By Trust) - Sale
Common Stock
[F1][F8][F3]2026-01-23$244.87/sh−390$95,500→ 21,782 total(indirect: By Trust)
Holdings
- 264,078
Common Stock
Footnotes (8)
- [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.02 to $242.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.1250 to $243.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.3759 to $245.1850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.13 to $242.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.34 to $243.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.4550 to $245.3900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-01-27